Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Models Which Explain the Inhibition of Reverse Transcriptase by HIV-1-Specific (Thio)carboxanilide Derivatives1 — Robert Esnouf (1997) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Models Which Explain the Inhibition of Reverse Transcriptase by HIV-1-Specific (Thio)carboxanilide Derivatives1
Shared by
De Clercq Erik
KU Leuven
Models Which Explain the Inhibition of Reverse Transcriptase by HIV-1-Specific (Thio)carboxanilide Derivatives1
Article
1997
en
Authors
+2 more
RE
Robert Esnouf
DS
David I. Stuart
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1992
Specific HIV-1 Reverse Transcriptase Inhibitors
Zeger Debyser
,
Rudi Pauwels
,
Koen Andries
,
De Clercq Erik
Article
1992
Highly potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by the HIV-1-specific reverse transcriptase inhibitors
Masanori Baba
,
Zeger Debyser
,
Shirô Shigeta
,
De Clercq Erik
Article
1990
HIV-1 specific inhibition of reverse transcriptase by TIBO-derivatives: a new mechanism of antiviral action discovered by drug screening
Rudi Pauwels
,
K Andries
,
Zeger Debyser
,
Jan Desmyter
,
De Clercq Erik
,
Paj Janssen
Letter
1994
How to overcome resistance of HIV-1 to HIV-1-specific reverse transcriptase inhibitors
De Clercq Erik
Article
1995
Oxathiin Carboxanilide Derivatives: A Class of Non-Nucleoside HIV-1-Specific Reverse Transcriptase Inhibitors (NNRTIs) that are Active against Mutant HIV-1 Strains Resistant to other NNRTIs
Jan Balzarini
,
Heidi Jonckheere
,
WilliamO. Harrison
,
D.C. Dao
,
Jozef Anné
,
De Clercq Erik
,
Anna Karlsson
Discussion(0)
No comments yet. Be the first to comment.